LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At close: November 8 at 4:00 PM EST ...

Featured here, the Balance Sheet for Vivos Therapeutics Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 ...

After hours: 8 November at 19:58 GMT-5 ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.